STOCK TITAN
  1. Home
  2. Sec-filings
  3. HIMS
  4. [Form 4] Hims & Hers Health, Inc. Insider Trading Activity

Hims & Hers Health (HIMS) director receives RSUs including fee-to-equity grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

WELLS DAVID B reported acquisition or exercise transactions in this Form 4 filing.

Hims & Hers Health, Inc. director David B. Wells reported two equity compensation awards in the form of Restricted Stock Units (RSUs). He received 8,223 RSUs, each representing one share of Class A common stock, which will vest in full on the first quarterly vesting date after the earlier of the next annual stockholder meeting or the first anniversary of the grant date, subject to continuous service. He also received 778 RSUs issued under the Director Compensation Policy in lieu of a $23,760 cash retainer for the second quarter of 2026, calculated at a grant price of $30.40 per share and vesting on the company’s next quarterly vesting date.

Positive

  • None.

Negative

  • None.
Insider WELLS DAVID B
Role Director
Type Security Shares Price Value
Grant/Award Restricted Stock Unit F1, F2 8,223 $0.00 $0.00
Grant/Award Restricted Stock Unit F1, F3 778 $0.00 $0.00
Holdings After Transaction: Restricted Stock Unit — 9,001 shares (Direct)
Footnotes (3)
  1. F1. The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU.
  2. F2. Subject to continuous service, the RSUs will vest in full on the first Company quarterly vesting date to occur after the earlier of (x) the date of the Company's next-occurring annual stockholder meeting or (y) the first anniversary of the grant date of the award.
  3. F3. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $23,760 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date.
RSUs granted (service-based award) 8,223 RSUs Grant of Restricted Stock Units vesting after the earlier of next annual meeting or first anniversary
RSUs granted in lieu of fees 778 RSUs RSUs issued under Director Compensation Policy in lieu of Q2 2026 cash retainer
Foregone cash fees $23,760 Director retainer fee for the second quarter of 2026 converted into RSUs
RSU grant price $30.40 Used to calculate 778 RSUs by dividing $23,760 of foregone fees
Underlying security per RSU 1 share Class A Common Stock Each RSU represents a contingent right to receive one share upon vesting
Restricted Stock Units financial
"The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
continuous service financial
"Subject to continuous service, the RSUs will vest in full on the first Company quarterly"
Director Compensation Policy financial
"The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy"
grant price financial
"calculated by dividing the foregone cash fees of $23,760 by the grant price of $30.40"

FAQ

What equity awards did HIMS director David B. Wells receive in this Form 4?
David B. Wells received two Restricted Stock Unit (RSU) grants: one for 8,223 RSUs and another for 778 RSUs. Each RSU represents a contingent right to receive one share of Hims & Hers Class A common stock upon vesting.

How and when do the 8,223 RSUs reported by HIMS vest?
The 8,223 RSUs vest in full on the first quarterly vesting date after the earlier of the company’s next annual stockholder meeting or the first anniversary of the grant. Vesting is explicitly conditioned on the director’s continuous service.

Why did HIMS grant 778 RSUs to director David B. Wells?
The 778 RSUs were issued under the company’s Director Compensation Policy in lieu of the second-quarter 2026 director retainer fee. The grant converts foregone cash fees of $23,760 into equity at a grant price of $30.40 per RSU.

When will the 778 RSUs granted to the HIMS director vest?
The 778 RSUs granted in lieu of cash fees will vest in full on the company’s next quarterly vesting date. Until vesting, they represent a contingent right to receive Class A common stock, subject to the applicable service conditions.

Are the RSU grants to the HIMS director tied to any Rule 10b5-1 trading plan?
The Form 4 indicates the Rule 10b5-1 trading plan checkbox is not marked as affirmative, meaning these RSU grants are reported as standard equity compensation awards rather than trades executed under a pre-arranged 10b5-1 plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
WELLS DAVID B
(Last)(First)(Middle)
2269 CHESTNUT STREET, #523
(Street)
SAN FRANCISCO CALIFORNIA 94123
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/12/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Unit(1)08/12/2026A8,223 (2) (2)Class A Common Stock8,223$08,223D
Restricted Stock Unit(1)08/12/2026A778 (3) (3)Class A Common Stock778$0778D
Explanation of Responses:
1. The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU.
2. Subject to continuous service, the RSUs will vest in full on the first Company quarterly vesting date to occur after the earlier of (x) the date of the Company's next-occurring annual stockholder meeting or (y) the first anniversary of the grant date of the award.
3. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $23,760 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date.
Remarks:
/s/ Kimberly Mather, Attorney-in-Fact for David B Wells08/14/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR